Back to Search
Start Over
Variables Influencing the Pressure and Volume of the Pulmonary Circulation as Risk Factors for Developing High Altitude Pulmonary Edema (HAPE).
- Source :
-
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Oct 26; Vol. 19 (21). Date of Electronic Publication: 2022 Oct 26. - Publication Year :
- 2022
-
Abstract
- Background: At altitudes above 2500 m, the risk of developing high altitude pulmonary edema (HAPE) grows with the increases in pulmonary arterial pressure. HAPE is characterized by severe pulmonary hypertension, though the incidence and relevance of individual risk factors are not yet predictable. However, the systolic pulmonary pressure (SPAP) and peak in tricuspid regurgitation velocity (TVR) are crucial factors when diagnosing pulmonary hypertension by echocardiography.<br />Methods: The SPAP and TVR of 27 trekkers aged 20-65 years en route to the Solu Khumbu region of Nepal were assessed. Echocardiograph measurements were performed at Lukla (2860 m), Gorak Shep (5170 m), and the summit of Kala Patthar (5675 m). The altitude profile and the participants' characteristics were also compiled for correlation with the measured data.<br />Results: The results showed a highly significant increase in SPAP and TVR after ascending Kala Patthar. The study revealed a lower increase of SPAP and TVR in the group of older participants, although the respective initial measurements at Gorak Shep were significantly higher for this group. A similar finding occurred in those using Diamox <superscript>®</superscript> as prophylaxis. There was an inverse relationship between TVR and SPAP, the peripheral capillary oxygen saturation, and heart rate.<br />Conclusions: The echocardiograph results indicated that older people are an at-risk group for developing HAPE. A conservative interpretation of the basic tactical rules for altitudes should be followed for older trekkers or trekkers with known problems of altitude acclimatization ("slow acclimatizer") as SPAP elevates with age. The prophylactic use of Acetazolamide (Diamox <superscript>®</superscript> ) should be avoided where not necessary for acute medical reasons. Acetazolamide leads to an increase of SPAP, and this may potentially enhance the risk of developing HAPE. Arterial oxygen saturation measurements can provide an indicator for the self-assessment for the risk of developing HAPE and a rule of thumb for the altitude profile, but does not replace a HAPE diagnosis. Backpack weight, sex, workload (actual ascent speed), and pre-existing diseases were not statistically significant factors related to SPAP and TVR ( p ≤ 0.05).
- Subjects :
- Humans
Aged
Altitude
Acetazolamide
Pulmonary Circulation
Risk Factors
Hypertension, Pulmonary diagnostic imaging
Hypertension, Pulmonary epidemiology
Pulmonary Edema diagnostic imaging
Pulmonary Edema epidemiology
Pulmonary Edema etiology
Altitude Sickness epidemiology
Altitude Sickness complications
Subjects
Details
- Language :
- English
- ISSN :
- 1660-4601
- Volume :
- 19
- Issue :
- 21
- Database :
- MEDLINE
- Journal :
- International journal of environmental research and public health
- Publication Type :
- Academic Journal
- Accession number :
- 36360767
- Full Text :
- https://doi.org/10.3390/ijerph192113887